First SARS-CoV-2 vaccine booster and influenza vaccination: risk assessment of COVID-19 hospitalisation and death | Epidemiologia&Prevenzione
Covid-19, Fda estende l'idoneità per la dose booster del vaccino Pfizer-BioNTech ai bambini da 5 a 11 anni - AboutPharma
Covid, al via la quarta dose per over 60 e soggetti fragili | Fondazione Umberto Veronesi
Coronavirus booster vaccine | Mencap
Boosters and time since the last anti-COVID-19 vaccine dose: lead public health choices by real-time epidemiological assessment | Epidemiologia&Prevenzione